Cure My Disease

Don't miss your cure!

 Log in / Sign up

Weight may weaken nerve therapy for stubborn constipation

NCT ID NCT07390682

Knowledge-focused Sponsor: General Committee of Teaching Hospitals and Institutes, Egypt Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked at 60 people with obstructed defecation, a severe form of constipation. Researchers compared how well a noninvasive nerve stimulation treatment worked in obese versus non-obese participants. The goal was to see if body weight changes the treatment's ability to improve symptoms and quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Feb 2026

Finished

Mar 2026

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of functional obstructed defecation (Rome IV criteria). * Able to provide informed consent. * BMI ≥30 kg/m² (obese group) or BMI \<30 kg/m² (non-obese group). Exclusion Criteria: * Organic causes of constipation (e.g., colorectal cancer, inflammatory bowel disease). * Previous pelvic floor surgery. * Neurological disorders affecting bowel function. * Pregnancy or lactation. * Current use of other neuromodulation therapies.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obstructed defecation are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anismus Obesity outlet dysfunction constipation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obstructed defecation

Contacts and locations

Locations

  • The surgical department of Medical Research Institute Hospital, Alexandria University

    Alexandria, 21531, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.